While many of these genes show a significant impact on OS or EFS in the TCGA AML cohort, further investigations are needed to clarify the roles and mechanisms of genes such as MPZL3, TREML2, and AHCYL1 in the context of AML. This evidence concerns the gene MPZL3 and acute myeloid leukemia.